CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Home Approval new drug product for Glaucoma diseases delivered with Nemera's Novelia®
News
8 Sep 2016

Approval new drug product for Glaucoma diseases delivered with Nemera's Novelia®

UK has approved a new drug product for Glaucoma diseases, delivered with Novelia®, Nemera’s multidose preservative-free eyedropper. The Novelia® system is the first and only preservative-free multidose eyedropper UK-approved for a glaucoma drug

Thanks to its unique innovative design, Novelia® has been approved as packaging component and delivery system of multidose drug product formulated without preservatives.

“This approval marks an important milestone for Novelia®” said Fanny Sellier, Category Manager of Nemera. “We’re excited to make it easier for UK patients to use preservative-free glaucoma drugs”

One way of keeping multi-dose eye droppers safe for patients is to add preservatives to the formulation. However, the use of preservatives can cause allergies or ocular irritation, and some can even cause a toxic response, damaging patients’ eyes[*]. Any such reactions are particular issues for patients who rely on the long term use of eye drops for chronic conditions, like glaucoma.

The alternative way to keep eye droppers clean is by the intelligent use of technology. Rather than relying on the anti-microbial properties of preservatives to kill any bacteria that enter the bottle, the ideal approach is to prevent any entry of bacteria into the bottle in the first place.
A viable alternative to the use of sterile filters for multi-dose preservative free eye droppers is a non-return valve system used in conjunction with a silicone membrane to filter the returning air. Novelia®: a multidose closing tip system avoids the need for preservatives in the drug and prevents bacterial contamination over the duration of treatment.

Discover Novelia® at CPHI WorldWide in Barcelona, at booth 2M38!

Nemera is a world leader in the design, development and manufacturing of drug delivery solutions. Its expertise covers all five modes of delivery: Ophthalmic (preservative-free multidose eyedroppers), Parenteral (autoinjectors, pens, safety devices & implanters), Pulmonary (pMDIs, DPIs), Nasal/Buccal/Auricular (spray pumps, actuators, valves, etc.), Dermal /Transdermal (airless & atmospheric dispensers). Nemera provides solutions for the pharmaceutical industry, including standard innovative products, the development of proprietary devices and contract manufacturing.

Learn more at www.nemera.net

[*] Report of the International Dry Eye Workshop. Ocul Surf 2007; 5[2]; 65-204.